Inventor · disambiguated record
Renaud Buffet
Also filed as: BUFFET RENAUD
6 granted patents·4 pending applications·18 citations·filing 2011–2024
79Inventor score
Top patents by PatentIndex Score
10 records- 0190US11078275B2Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphomaINNATE PHARMA·Filed 2019·Granted Aug 3, 2021·3 cites·12 claims
- 0290US10174112B2Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphomaINNATE PHARMA·Filed 2017·Granted Jan 8, 2019·9 cites·12 claims
- 0387US2025092130A1Compound that specifically binds to kir3dl2 for use in the treatment of peripheral t cell lymphomaINNATE PHARMA·Filed 2024·Application pending·0 cites
- 0482US10344087B2Treatment of peripheral T cell lymphomaINNATE PHARMA·Filed 2014·Granted Jul 9, 2019·3 cites·7 claims
- 0582US2024425586A1Treatment of peripheral t cell lymphomaINNATE PHARMA·Filed 2024·Application pending·0 cites
- 0676US12084498B2Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphomaINNATE PHARMA·Filed 2021·Granted Sep 10, 2024·0 cites·13 claims
- 0772US9844593B2Methods for treatment of recurrent hematological malignanciesANDRE PASCALE·Filed 2011·Granted Dec 19, 2017·3 cites·10 claims
- 0871US11999784B2Treatment of peripheral T cell lymphomaINNATE PHARMA·Filed 2019·Granted Jun 4, 2024·0 cites·1 claims
- 0960US2016002345A1A compound that specifically binds to kir3dl2 for use in the treatment of peripheral t cell lymphomaINNATE PHARMA·Filed 2014·Application pending·0 cites
- 1043US2016136272A1Methods for restoring corticosteroid sensitivityINNATE PHARMA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Renaud Buffet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →